BioNote, Inc. (KRX:377740)
5,150.00
-20.00 (-0.39%)
Last updated: Apr 29, 2026, 2:16 PM KST
BioNote Revenue
In the year 2025, BioNote had annual revenue of 118.32B KRW with 15.12% growth. BioNote had revenue of 27.97B in the quarter ending December 31, 2025, with 13.05% growth.
Revenue
118.32B
Revenue Growth
+15.12%
P/S Ratio
4.41
Revenue / Employee
397.06M
Employees
298
Market Cap
522.33B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| T&L Co., Ltd. | 164.16B |
| Value Added Technology | 426.42B |
| Vieworks | 239.33B |
| Dongbang Medical | 113.54B |
| Shinhung | 102.61B |
| CLASSYS | 336.82B |
| EOFLOW | 3.67B |
| PCL, Inc. | 4.98B |